Carcharodon carcharias isolate sCarCar2 chromosome 26, sCarCar2.pri, whole genome shotgun sequence.
Carcharodon carcharias (great white shark)
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Chondrichthyes; Elasmobranchii; Galeomorphii; Galeoidea; Lamniformes; Alopiidae; Carcharodon.
REFSEQ INFORMATION: The reference sequence is identical to\nCM029990.1.\nAssembly name: sCarCar2.pri\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Vertebrate Genomes Project on\n2021/03/30. The original whole-genome shotgun project has the\naccession JAGDEE000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Vertebrate Genomes Project\nAssembly Date :: 05-FEB-2021\nAssembly Method :: FALCON v. DX 2.0.1; FALCON-Unzip v. DX\n 1.2.1; purge_dups v. DX 19-08-10;\n scaff10X v. DX 2.0.3; bionano Solve v. DX\n 3.4.0; Salsa2 HiC v. DX 2.2.0; Arrow\n polishing and gap filling v. DX 7.0.1.1;\n Longranger Align DX v. 2.2.2.1; freebayes\n DX v. 19-07-11; gEVAL manual curation v.\n 2021-02-05; VGP assembly pipeline v. 1.6\nAssembly Name :: sCarCar2.pri\nDiploid :: Principal Pseudohaplotype\nGenome Representation :: Full\nExpected Final Version :: No\nGenome Coverage :: 66.84x\nSequencing Technology :: PacBio Sequel I CLR; Illumina NovaSeq;\n Arima Genomics Hi-C; Bionano Genomics DLS\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Carcharodon carcharias Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 8.6\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
SPG21 abhydrolase domain containing, maspardin, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
SPG21 abhydrolase domain containing, maspardin, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
SPG21 abhydrolase domain containing, maspardin, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins
ankyrin repeat and death domain containing 1A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ankyrin repeat and death domain containing 1A, transcript variant X1
ankyrin repeat and death domain-containing protein 1A isoform X2
ankyrin repeat and death domain-containing protein 1A isoform X1
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00563
calcium-binding mitochondrial carrier protein SCaMC-3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins
pleckstrin homology domain-containing family O member 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
small nuclear ribonucleoprotein polypeptide A'
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
leucine-rich repeat kinase 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
leucine-rich repeat kinase 1, transcript variant X1
leucine-rich repeat serine/threonine-protein kinase 1 isoform X3
leucine-rich repeat serine/threonine-protein kinase 1 isoform X1
leucine-rich repeat kinase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
leucine-rich repeat serine/threonine-protein kinase 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
aldehyde dehydrogenase 1 family, member A3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 61 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
aldehyde dehydrogenase family 1 member A3
ankyrin repeat and SOCS box containing 7, transcript variant X5
ankyrin repeat and SOCS box containing 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ankyrin repeat and SOCS box containing 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ankyrin repeat and SOCS box containing 7, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ankyrin repeat and SOCS box containing 7, transcript variant X3
ankyrin repeat and SOCS box protein 7 isoform X1
ankyrin repeat and SOCS box protein 7 isoform X3
ankyrin repeat and SOCS box protein 7 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ceramide synthase 3a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ceramide synthase 3a, transcript variant X1
ceramide synthase 3a, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ADAM metallopeptidase with thrombospondin type 1 motif, 17, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ADAM metallopeptidase with thrombospondin type 1 motif, 17, transcript variant X2
A disintegrin and metalloproteinase with thrombospondin motifs 17 isoform X1
A disintegrin and metalloproteinase with thrombospondin motifs 17 isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
membrane integral NOTCH2 associated receptor 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins
major intrinsically disordered Notch2-binding receptor 1
5,10-methenyltetrahydrofolate synthetase (5-formyltetrahydrofolate cyclo-ligase)
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
complement C1q tumor necrosis factor-related protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00015
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
zinc finger, AN1-type domain 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zinc finger, AN1-type domain 6, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zinc finger, AN1-type domain 6, transcript variant X6
zinc finger, AN1-type domain 6, transcript variant X10
zinc finger, AN1-type domain 6, transcript variant X7
zinc finger, AN1-type domain 6, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zinc finger, AN1-type domain 6, transcript variant X11
zinc finger, AN1-type domain 6, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
zinc finger, AN1-type domain 6, transcript variant X2
zinc finger, AN1-type domain 6, transcript variant X4
zinc finger, AN1-type domain 6, transcript variant X5
zinc finger, AN1-type domain 6, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
AN1-type zinc finger protein 6 isoform X1
AN1-type zinc finger protein 6 isoform X4
AN1-type zinc finger protein 6 isoform X2
AN1-type zinc finger protein 6 isoform X6
AN1-type zinc finger protein 6 isoform X3
AN1-type zinc finger protein 6 isoform X5
AN1-type zinc finger protein 6 isoform X7
zinc finger, AN1-type domain 6, transcript variant X14
zinc finger, AN1-type domain 6, transcript variant X13
zinc finger, AN1-type domain 6, transcript variant X15
AN1-type zinc finger protein 6 isoform X8
fumarylacetoacetate hydrolase (fumarylacetoacetase), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
fumarylacetoacetate hydrolase (fumarylacetoacetase), transcript variant X3
fumarylacetoacetate hydrolase (fumarylacetoacetase), transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
aryl-hydrocarbon receptor nuclear translocator 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
aryl-hydrocarbon receptor nuclear translocator 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
aryl-hydrocarbon receptor nuclear translocator 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
aryl-hydrocarbon receptor nuclear translocator 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
aryl-hydrocarbon receptor nuclear translocator 2, transcript variant X3
aryl-hydrocarbon receptor nuclear translocator 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
aryl-hydrocarbon receptor nuclear translocator 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
aryl-hydrocarbon receptor nuclear translocator 2, transcript variant X8
aryl hydrocarbon receptor nuclear translocator 2 isoform X1
aryl hydrocarbon receptor nuclear translocator 2 isoform X3
aryl hydrocarbon receptor nuclear translocator 2 isoform X4
COORDINATES: nucleotide motif:Rfam:12.0:RF00548
aryl hydrocarbon receptor nuclear translocator 2 isoform X2
abhydrolase domain containing 17C, depalmitoylase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
alpha/beta hydrolase domain-containing protein 17C
cell migration inducing hyaluronidase 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cell migration inducing hyaluronidase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cell migration inducing hyaluronidase 1, transcript variant X2
cell migration-inducing and hyaluronan-binding protein isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
cilia and flagella associated protein 161
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cilia- and flagella-associated protein 161
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
StAR-related lipid transfer (START) domain containing 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transmembrane channel-like protein 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
transmembrane channel-like protein 3, transcript variant X4
transmembrane channel-like protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
transmembrane channel-like protein 3, transcript variant X1
transmembrane channel-like protein 3, transcript variant X5
transmembrane channel-like protein 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transmembrane channel-like protein 3 isoform X3
transmembrane channel-like protein 3 isoform X4
transmembrane channel-like protein 3 isoform X2
transmembrane channel-like protein 3 isoform X1
transmembrane channel-like protein 3 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
elongation factor like GTPase 1, transcript variant X1
elongation factor like GTPase 1, transcript variant X2
elongation factor-like GTPase 1 isoform X2
elongation factor-like GTPase 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized protein LOC791214 homolog, transcript variant X2
uncharacterized protein LOC791214 homolog, transcript variant X1
SH3-domain GRB2-like 3a, transcript variant X5
SH3-domain GRB2-like 3a, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
SH3-domain GRB2-like 3a, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
SH3-domain GRB2-like 3a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
SH3-domain GRB2-like 3a, transcript variant X2
SH3-domain GRB2-like 3a, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zinc finger protein basonuclin-2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
zinc finger protein basonuclin-2 isoform X1
zinc finger protein basonuclin-2 isoform X3
uncharacterized LOC121269771, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC121269771, transcript variant X1
hepatoma-derived growth factor-related protein 3
transmembrane 6 superfamily member 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transmembrane 6 superfamily member 1-like isoform X1
transmembrane 6 superfamily member 1-like, transcript variant X2
transmembrane 6 superfamily member 1-like, transcript variant X4
transmembrane 6 superfamily member 1-like, transcript variant X3
transmembrane 6 superfamily member 1-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
isocitrate dehydrogenase [NADP], mitochondrial
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
zinc finger protein 710a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
zinc finger protein 710a, transcript variant X2
zinc finger protein 710a, transcript variant X3
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4Ba, transcript variant X6
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4Ba, transcript variant X5
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4Ba, transcript variant X9
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4Ba, transcript variant X12
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4Ba, transcript variant X1
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4Ba, transcript variant X3
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4Ba, transcript variant X4
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4Ba, transcript variant X2
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4Ba, transcript variant X8
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4Ba, transcript variant X11
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4Ba, transcript variant X10
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4Ba, transcript variant X7
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4Ba isoform X1
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4Ba, transcript variant X13
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4Ba isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins
ras and EF-hand domain-containing protein, transcript variant X1
ras and EF-hand domain-containing protein, transcript variant X2
ras and EF-hand domain-containing protein isoform X1
ras and EF-hand domain-containing protein isoform X2
ras and EF-hand domain-containing protein, transcript variant X3
ras and EF-hand domain-containing protein isoform X3
uncharacterized protein LOC100149345 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized protein LOC100149345 homolog, transcript variant X2
uncharacterized protein LOC100149345 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 96% coverage of the annotated genomic feature by RNAseq alignments
RNA polymerase II elongation factor ELL, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
RNA polymerase II elongation factor ELL, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
RNA polymerase II elongation factor ELL isoform X1
RNA polymerase II elongation factor ELL isoform X2
multiple C2 and transmembrane domain-containing protein 2-like, transcript variant X1
multiple C2 and transmembrane domain-containing protein 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
multiple C2 and transmembrane domain-containing protein 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
multiple C2 and transmembrane domain-containing protein 2-like isoform X1
multiple C2 and transmembrane domain-containing protein 2-like isoform X3
multiple C2 and transmembrane domain-containing protein 2-like isoform X2
COUP transcription factor 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
COUP transcription factor 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 79 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
COUP transcription factor 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
COUP transcription factor 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC121269780, transcript variant X2
uncharacterized LOC121269780, transcript variant X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
arrestin domain-containing protein 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
LysM, putative peptidoglycan-binding, domain containing 4, transcript variant X2
LysM, putative peptidoglycan-binding, domain containing 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
lysM and putative peptidoglycan-binding domain-containing protein 4
myocyte enhancer factor 2aa, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
myocyte enhancer factor 2aa, transcript variant X14
myocyte enhancer factor 2aa, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
myocyte enhancer factor 2aa, transcript variant X12
myocyte enhancer factor 2aa, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
myocyte enhancer factor 2aa, transcript variant X7
myocyte enhancer factor 2aa, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
myocyte enhancer factor 2aa, transcript variant X10
myocyte enhancer factor 2aa, transcript variant X15
myocyte enhancer factor 2aa, transcript variant X8
myocyte enhancer factor 2aa, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
myocyte enhancer factor 2aa, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
myocyte enhancer factor 2aa, transcript variant X5
myocyte enhancer factor 2aa, transcript variant X9
myocyte enhancer factor 2aa, transcript variant X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
myocyte enhancer factor 2aa, transcript variant X2
myocyte enhancer factor 2aa, transcript variant X4
leucine rich repeat containing 28, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
leucine rich repeat containing 28, transcript variant X2
leucine rich repeat containing 28, transcript variant X3
leucine rich repeat containing 28, transcript variant X6
leucine rich repeat containing 28, transcript variant X7
leucine rich repeat containing 28, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
leucine rich repeat containing 28, transcript variant X5
leucine rich repeat containing 28, transcript variant X4
leucine rich repeat containing 28, transcript variant X8
leucine rich repeat containing 28, transcript variant X9
leucine-rich repeat-containing protein 28 isoform X2
leucine-rich repeat-containing protein 28 isoform X1
leucine-rich repeat-containing protein 28 isoform X5
leucine-rich repeat-containing protein 28 isoform X4
leucine-rich repeat-containing protein 28 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 79% coverage of the annotated genomic feature by RNAseq alignments
cation channel sperm-associated protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 83% coverage of the annotated genomic feature by RNAseq alignments
protein disulfide isomerase family A, member 3
protein unc-13 homolog C-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein unc-13 homolog C-like, transcript variant X2
protein unc-13 homolog C-like, transcript variant X3
protein unc-13 homolog B-like isoform X1
protein unc-13 homolog B-like isoform X3
protein unc-13 homolog B-like isoform X2
protein unc-13 homolog C-like, transcript variant X4
protein unc-13 homolog C-like isoform X4
protein unc-13 homolog C-like, transcript variant X5
protein unc-13 homolog C-like isoform X5
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glycine (anticodon CCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
probable ribosome biogenesis protein RLP24
RAB27A, member RAS oncogene family, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
RAB27A, member RAS oncogene family, transcript variant X1
RAB27A, member RAS oncogene family, transcript variant X3
RAB27A, member RAS oncogene family, transcript variant X5
RAB27A, member RAS oncogene family, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
cell cycle progression 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cell cycle progression 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cell cycle progression 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cell cycle progression 1, transcript variant X1
cell cycle progression protein 1 isoform X4
cell cycle progression protein 1 isoform X2
cell cycle progression protein 1 isoform X3
cell cycle progression protein 1 isoform X1
cell cycle progression 1, transcript variant X5
cell cycle progression protein 1 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
dynein axonemal assembly factor 4, transcript variant X2
dynein axonemal assembly factor 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cartilage intermediate layer protein 1-like, transcript variant X1
cartilage intermediate layer protein 1-like, transcript variant X3
cartilage intermediate layer protein 1-like, transcript variant X2
cartilage intermediate layer protein 1-like isoform X1
cartilage intermediate layer protein 1-like isoform X2
mitochondrial methionyl-tRNA formyltransferase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
methionyl-tRNA formyltransferase, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
adaptor related protein complex 3 subunit sigma 2, transcript variant X2
adaptor related protein complex 3 subunit sigma 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
actin related protein 2/3 complex inhibitor, transcript variant X1
actin related protein 2/3 complex inhibitor, transcript variant X2
spermatogenesis associated 5-like 1, transcript variant X1
spermatogenesis-associated protein 5-like protein 1
spermatogenesis associated 5-like 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
normal mucosa of esophagus-specific gene 1 protein
solute carrier family 30 member 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
solute carrier family 30 member 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
biogenesis of lysosomal organelles complex-1, subunit 6, pallidin
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
biogenesis of lysosome-related organelles complex 1 subunit 6
sulfide:quinone oxidoreductase, mitochondrial
signal peptide peptidase-like 2A, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
signal peptide peptidase-like 2A, transcript variant X2
signal peptide peptidase-like 2A, transcript variant X1
signal peptide peptidase-like 2A, transcript variant X4
signal peptide peptidase-like 2A, transcript variant X3
signal peptide peptidase-like 2A isoform X1
signal peptide peptidase-like 2A isoform X3
signal peptide peptidase-like 2A isoform X2
signal peptide peptidase-like 2A isoform X4
signal peptide peptidase-like 2A isoform X5
transient receptor potential cation channel, subfamily M, member 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transient receptor potential cation channel, subfamily M, member 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transient receptor potential cation channel, subfamily M, member 7, transcript variant X4
transient receptor potential cation channel, subfamily M, member 7, transcript variant X3
transient receptor potential cation channel, subfamily M, member 7, transcript variant X6
transient receptor potential cation channel subfamily M member 7 isoform X1
transient receptor potential cation channel subfamily M member 7 isoform X3
transient receptor potential cation channel subfamily M member 7 isoform X6
transient receptor potential cation channel subfamily M member 7 isoform X2
transient receptor potential cation channel subfamily M member 7 isoform X4
transient receptor potential cation channel, subfamily M, member 7, transcript variant X5
transient receptor potential cation channel subfamily M member 7 isoform X5
uncharacterized LOC121269968, transcript variant X2
uncharacterized LOC121269968, transcript variant X1
putative ubiquitin carboxyl-terminal hydrolase 50
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 12% coverage of the annotated genomic feature by RNAseq alignments
ubiquitin specific peptidase 8, transcript variant X4
ubiquitin specific peptidase 8, transcript variant X3
ubiquitin specific peptidase 8, transcript variant X1
ubiquitin specific peptidase 8, transcript variant X2
ubiquitin specific peptidase 8, transcript variant X7
ubiquitin specific peptidase 8, transcript variant X6
ubiquitin specific peptidase 8, transcript variant X5
ubiquitin carboxyl-terminal hydrolase 8 isoform X3
ubiquitin carboxyl-terminal hydrolase 8 isoform X2
ubiquitin carboxyl-terminal hydrolase 8 isoform X1
GA binding protein transcription factor subunit beta 1, transcript variant X7
GA binding protein transcription factor subunit beta 1, transcript variant X5
GA binding protein transcription factor subunit beta 1, transcript variant X9
GA binding protein transcription factor subunit beta 1, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
GA binding protein transcription factor subunit beta 1, transcript variant X8
GA binding protein transcription factor subunit beta 1, transcript variant X4
GA binding protein transcription factor subunit beta 1, transcript variant X6
GA binding protein transcription factor subunit beta 1, transcript variant X1
GA binding protein transcription factor subunit beta 1, transcript variant X3
GA binding protein transcription factor subunit beta 1, transcript variant X11
GA binding protein transcription factor subunit beta 1, transcript variant X12
GA binding protein transcription factor subunit beta 1, transcript variant X2
GA-binding protein subunit beta-1 isoform X6
GA-binding protein subunit beta-1 isoform X1
GA-binding protein subunit beta-1 isoform X5
GA-binding protein subunit beta-1 isoform X3
GA-binding protein subunit beta-1 isoform X7
GA-binding protein subunit beta-1 isoform X8
GA-binding protein subunit beta-1 isoform X4
GA-binding protein subunit beta-1 isoform X2
GA-binding protein subunit beta-1 isoform X9
GA-binding protein subunit beta-1 isoform X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 55% coverage of the annotated genomic feature by RNAseq alignments
very long-chain acyl-CoA synthetase-like
glycine amidinotransferase (L-arginine:glycine amidinotransferase)
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glycine amidinotransferase, mitochondrial
phosphodiesterase 8A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
phosphodiesterase 8A, transcript variant X2
high affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A isoform X1
phosphodiesterase 8A, transcript variant X3
high affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A isoform X2
fibronectin type III and SPRY domain-containing protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
WASP homolog-associated protein with actin, membranes and microtubules
homer scaffold protein 2, transcript variant X2
homer scaffold protein 2, transcript variant X4
homer scaffold protein 2, transcript variant X3
homer scaffold protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC121270004, transcript variant X1
uncharacterized LOC121270004, transcript variant X3
uncharacterized protein LOC121270004 isoform X1
uncharacterized protein LOC121270004 isoform X3
uncharacterized LOC121270004, transcript variant X2
uncharacterized protein LOC121270004 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
chromosome 26 C15orf40 homolog, transcript variant X4
chromosome 26 C15orf40 homolog, transcript variant X5
chromosome 26 C15orf40 homolog, transcript variant X2
chromosome 26 C15orf40 homolog, transcript variant X1
chromosome 26 C15orf40 homolog, transcript variant X3
UPF0235 protein C15orf40 homolog isoform X4
UPF0235 protein C15orf40 homolog isoform X5
UPF0235 protein C15orf40 homolog isoform X2
UPF0235 protein C15orf40 homolog isoform X1
UPF0235 protein C15orf40 homolog isoform X3
very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins
DENN/MADD domain containing 4A, transcript variant X13
DENN/MADD domain containing 4A, transcript variant X9
DENN/MADD domain containing 4A, transcript variant X8
DENN/MADD domain containing 4A, transcript variant X11
DENN/MADD domain containing 4A, transcript variant X7
DENN/MADD domain containing 4A, transcript variant X4
DENN/MADD domain containing 4A, transcript variant X10
DENN/MADD domain containing 4A, transcript variant X12
DENN/MADD domain containing 4A, transcript variant X6
DENN/MADD domain containing 4A, transcript variant X5
DENN/MADD domain containing 4A, transcript variant X1
DENN/MADD domain containing 4A, transcript variant X3
DENN/MADD domain containing 4A, transcript variant X2
C-myc promoter-binding protein isoform X11
C-myc promoter-binding protein isoform X7
C-myc promoter-binding protein isoform X6
C-myc promoter-binding protein isoform X9
C-myc promoter-binding protein isoform X5
C-myc promoter-binding protein isoform X2
C-myc promoter-binding protein isoform X8
C-myc promoter-binding protein isoform X10
C-myc promoter-binding protein isoform X4
C-myc promoter-binding protein isoform X3
C-myc promoter-binding protein isoform X1
transfer RNA glutamine (anticodon CUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 147 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
multiple EGF-like-domains 11, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 59% coverage of the annotated genomic feature by RNAseq alignments
multiple EGF-like-domains 11, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 56% coverage of the annotated genomic feature by RNAseq alignments
multiple epidermal growth factor-like domains protein 11 isoform X1
multiple epidermal growth factor-like domains protein 11 isoform X2
DIS3 like exosome 3'-5' exoribonuclease, transcript variant X1
DIS3 like exosome 3'-5' exoribonuclease, transcript variant X2
DIS3 like exosome 3'-5' exoribonuclease, transcript variant X4
DIS3 like exosome 3'-5' exoribonuclease, transcript variant X3
timeless interacting protein, transcript variant X3
timeless interacting protein, transcript variant X1
timeless interacting protein, transcript variant X2
mitogen-activated protein kinase kinase 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
dual specificity mitogen-activated protein kinase kinase 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00093
COORDINATES: nucleotide motif:Rfam:12.0:RF00138
zwilch kinetochore protein, transcript variant X2
zwilch kinetochore protein, transcript variant X1
zwilch kinetochore protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 49% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 28% coverage of the annotated genomic feature by RNAseq alignments
small nuclear RNA activating complex, polypeptide 5, transcript variant X3
small nuclear RNA activating complex, polypeptide 5, transcript variant X2
small nuclear RNA activating complex, polypeptide 5, transcript variant X1
snRNA-activating protein complex subunit 5
uncharacterized protein LOC407663 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 63 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized protein LOC407663 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins
ankyrin repeat domain-containing protein 34C
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 82% coverage of the annotated genomic feature by RNAseq alignments
Ras protein specific guanine nucleotide releasing factor 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 17% coverage of the annotated genomic feature by RNAseq alignments
ras-specific guanine nucleotide-releasing factor 1
BLM RecQ like helicase, transcript variant X1
BLM RecQ like helicase, transcript variant X3
BLM RecQ like helicase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Bloom syndrome protein homolog isoform X1
Bloom syndrome protein homolog isoform X2
BLM RecQ like helicase, transcript variant X4
Bloom syndrome protein homolog isoform X3
FERM domain-containing protein 5-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
FERM domain-containing protein 5-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 74% coverage of the annotated genomic feature by RNAseq alignments
FERM domain-containing protein 5-like isoform X1
FERM domain-containing protein 5-like isoform X2
golgi membrane protein 2, transcript variant X1
golgi membrane protein 2, transcript variant X2
CTD small phosphatase-like protein 2, transcript variant X2
CTD small phosphatase-like protein 2, transcript variant X1
CTD small phosphatase-like protein 2, transcript variant X4
CTD small phosphatase-like protein 2, transcript variant X3
CTD small phosphatase-like protein 2 isoform X1
CTD small phosphatase-like protein 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 59% coverage of the annotated genomic feature by RNAseq alignments
eukaryotic translation initiation factor 3 subunit J-like, transcript variant X1
eukaryotic translation initiation factor 3 subunit J-like isoform X1
eukaryotic translation initiation factor 3 subunit J-like, transcript variant X2
eukaryotic translation initiation factor 3 subunit J-like isoform X2
SPG11 vesicle trafficking associated, spatacsin, transcript variant X2
SPG11 vesicle trafficking associated, spatacsin, transcript variant X1
SPG11 vesicle trafficking associated, spatacsin, transcript variant X3
SPG11 vesicle trafficking associated, spatacsin, transcript variant X5
SPG11 vesicle trafficking associated, spatacsin, transcript variant X4
cytosolic iron-sulfur assembly component 2A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cytosolic iron-sulfur assembly component 2A, transcript variant X3
cytosolic iron-sulfur assembly component 2A, transcript variant X1
cytosolic iron-sulfur assembly component 2A isoform X2
cytosolic iron-sulfur assembly component 2A isoform X3
cytosolic iron-sulfur assembly component 2A isoform X1
A disintegrin and metalloproteinase with thrombospondin motifs 7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins
transfer RNA lysine (anticodon CUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
mortality factor 4 like 1, transcript variant X2
mortality factor 4 like 1, transcript variant X1
mortality factor 4 like 1, transcript variant X3
mortality factor 4-like protein 1 isoform X1
mortality factor 4-like protein 1 isoform X2
uveal autoantigen with coiled-coil domains and ankyrin repeats a, transcript variant X1
uveal autoantigen with coiled-coil domains and ankyrin repeats a, transcript variant X4
uveal autoantigen with coiled-coil domains and ankyrin repeats a, transcript variant X2
uveal autoantigen with coiled-coil domains and ankyrin repeats a, transcript variant X5
uveal autoantigen with coiled-coil domains and ankyrin repeats isoform X1
uveal autoantigen with coiled-coil domains and ankyrin repeats isoform X4
uveal autoantigen with coiled-coil domains and ankyrin repeats isoform X2
uveal autoantigen with coiled-coil domains and ankyrin repeats isoform X5
uveal autoantigen with coiled-coil domains and ankyrin repeats a, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uveal autoantigen with coiled-coil domains and ankyrin repeats isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins
transducin-like enhancer protein 3, transcript variant X1
transducin-like enhancer protein 3, transcript variant X5
transducin-like enhancer protein 3, transcript variant X3
transducin-like enhancer protein 3, transcript variant X2
transducin-like enhancer protein 3, transcript variant X4
transducin-like enhancer protein 3, transcript variant X6
transducin-like enhancer protein 3, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transducin-like enhancer protein 3, transcript variant X7
transducin-like enhancer protein 3, transcript variant X9
transducin-like enhancer protein 3, transcript variant X8
transducin-like enhancer protein 3, transcript variant X10
transducin-like enhancer protein 3, transcript variant X12
transducin-like enhancer protein 3, transcript variant X13
transducin-like enhancer protein 3, transcript variant X14
transducin-like enhancer protein 3 isoform X1
transducin-like enhancer protein 3 isoform X5
transducin-like enhancer protein 3 isoform X3
transducin-like enhancer protein 3 isoform X2
transducin-like enhancer protein 3 isoform X4
transducin-like enhancer protein 3 isoform X6
transducin-like enhancer protein 3 isoform X11
transducin-like enhancer protein 3 isoform X7
transducin-like enhancer protein 3 isoform X9
transducin-like enhancer protein 3 isoform X8
transducin-like enhancer protein 3 isoform X10
transducin-like enhancer protein 3 isoform X12
transducin-like enhancer protein 3 isoform X13
transducin-like enhancer protein 3 isoform X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 70 Proteins
kinesin family member 23, transcript variant X4
kinesin family member 23, transcript variant X2
kinesin family member 23, transcript variant X5
kinesin family member 23, transcript variant X3
kinesin family member 23, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
mothers against decapentaplegic homolog 6b
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 71 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
mothers against decapentaplegic homolog 3b
alpha and gamma adaptin binding protein, transcript variant X2
alpha and gamma adaptin binding protein, transcript variant X1
alpha- and gamma-adaptin-binding protein p34 isoform X2
alpha- and gamma-adaptin-binding protein p34 isoform X1
IQ motif containing H, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
IQ motif containing H, transcript variant X2
IQ motif-containing protein H isoform X1
IQ motif containing H, transcript variant X3
IQ motif-containing protein H isoform X2
uncharacterized protein C15orf61 homolog
mitogen-activated protein kinase kinase 5, transcript variant X9
mitogen-activated protein kinase kinase 5, transcript variant X1
mitogen-activated protein kinase kinase 5, transcript variant X2
mitogen-activated protein kinase kinase 5, transcript variant X7
mitogen-activated protein kinase kinase 5, transcript variant X4
mitogen-activated protein kinase kinase 5, transcript variant X3
mitogen-activated protein kinase kinase 5, transcript variant X5
mitogen-activated protein kinase kinase 5, transcript variant X10
mitogen-activated protein kinase kinase 5, transcript variant X6
mitogen-activated protein kinase kinase 5, transcript variant X8
dual specificity mitogen-activated protein kinase kinase 5 isoform X1
dual specificity mitogen-activated protein kinase kinase 5 isoform X2
dual specificity mitogen-activated protein kinase kinase 5 isoform X7
dual specificity mitogen-activated protein kinase kinase 5 isoform X4
dual specificity mitogen-activated protein kinase kinase 5 isoform X3
dual specificity mitogen-activated protein kinase kinase 5 isoform X5
dual specificity mitogen-activated protein kinase kinase 5 isoform X10
dual specificity mitogen-activated protein kinase kinase 5 isoform X6
dual specificity mitogen-activated protein kinase kinase 5 isoform X8
dual specificity mitogen-activated protein kinase kinase 5 isoform X9
SKI family transcriptional corepressor 1 homolog-B-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 73% coverage of the annotated genomic feature by RNAseq alignments
protein inhibitor of activated STAT, 1b, transcript variant X1
protein inhibitor of activated STAT, 1b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
calmodulin-like protein 4, transcript variant X2
calmodulin-like protein 4, transcript variant X3
calmodulin-like protein 4, transcript variant X1
calmodulin-like protein 4, transcript variant X4
ceroid-lipofuscinosis neuronal protein 6 homolog, transcript variant X3
ceroid-lipofuscinosis neuronal protein 6 homolog, transcript variant X2
ceroid-lipofuscinosis neuronal protein 6 homolog, transcript variant X1
ceroid-lipofuscinosis neuronal protein 6 homolog, transcript variant X4
ceroid-lipofuscinosis neuronal protein 6 homolog isoform X1
ceroid-lipofuscinosis neuronal protein 6 homolog isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
coronin, actin binding protein, 2Ba, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
coronin, actin binding protein, 2Ba, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
coronin, actin binding protein, 2Ba, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
acidic (leucine-rich) nuclear phosphoprotein 32 family, member A
acidic leucine-rich nuclear phosphoprotein 32 family member A
NADPH oxidase, EF-hand calcium binding domain 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
D-glucuronyl C5-epimerase-like, transcript variant X6
D-glucuronyl C5-epimerase-like, transcript variant X5
D-glucuronyl C5-epimerase-like, transcript variant X7
D-glucuronyl C5-epimerase-like, transcript variant X4
D-glucuronyl C5-epimerase-like, transcript variant X2
D-glucuronyl C5-epimerase-like, transcript variant X8
D-glucuronyl C5-epimerase-like, transcript variant X3
D-glucuronyl C5-epimerase-like, transcript variant X1
D-glucuronyl C5-epimerase-like isoform X1
D-glucuronyl C5-epimerase-like isoform X2
membrane progestin receptor gamma-B-like, transcript variant X2
membrane progestin receptor gamma-B-like, transcript variant X1
membrane progestin receptor gamma-B-like, transcript variant X4
membrane progestin receptor gamma-B-like, transcript variant X3
membrane progestin receptor gamma-B-like
transmembrane emp24 domain-containing protein 3-like
interferon-stimulated gene 20 kDa protein-like
apoptosis-enhancing nuclease-like, transcript variant X3
apoptosis-enhancing nuclease-like isoform X2
apoptosis-enhancing nuclease-like, transcript variant X1
apoptosis-enhancing nuclease-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
apoptosis-enhancing nuclease-like isoform X1
kelch-like protein 25, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 60 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
kelch-like protein 25, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 60 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
kelch-like protein 25, transcript variant X1
kelch-like protein 25, transcript variant X5
kelch-like protein 25, transcript variant X3
A-kinase anchor protein 13-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
A-kinase anchor protein 13-like, transcript variant X4
A-kinase anchor protein 13-like, transcript variant X5
A-kinase anchor protein 13-like, transcript variant X9
A-kinase anchor protein 13-like, transcript variant X3
A-kinase anchor protein 13-like, transcript variant X2
A-kinase anchor protein 13-like, transcript variant X1
A-kinase anchor protein 13-like, transcript variant X7
A-kinase anchor protein 13-like, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
A-kinase anchor protein 13-like, transcript variant X8
A-kinase anchor protein 13-like, transcript variant X10
A-kinase anchor protein 13-like isoform X7
A-kinase anchor protein 13-like isoform X3
A-kinase anchor protein 13-like isoform X2
A-kinase anchor protein 13-like isoform X1
A-kinase anchor protein 13-like isoform X4
A-kinase anchor protein 13-like isoform X5
A-kinase anchor protein 13-like isoform X6
A-kinase anchor protein 13-like isoform X9
A-kinase anchor protein 13-like isoform X8
synaptic vesicle glycoprotein 2B-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 77% coverage of the annotated genomic feature by RNAseq alignments
synaptic vesicle glycoprotein 2B-like isoform X3
synaptic vesicle glycoprotein 2B-like, transcript variant X1
synaptic vesicle glycoprotein 2B-like isoform X1
synaptic vesicle glycoprotein 2B-like, transcript variant X2
synaptic vesicle glycoprotein 2B-like isoform X2
solute carrier organic anion transporter family, member 3A1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 75% coverage of the annotated genomic feature by RNAseq alignments
solute carrier organic anion transporter family member 3A1
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 58% coverage of the annotated genomic feature by RNAseq alignments
CTS telomere maintenance complex component 1, transcript variant X2
CTS telomere maintenance complex component 1, transcript variant X3
CTS telomere maintenance complex component 1, transcript variant X1
chromodomain helicase DNA binding protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
chromodomain helicase DNA binding protein 2, transcript variant X2
chromodomain helicase DNA binding protein 2, transcript variant X3
chromodomain-helicase-DNA-binding protein 2 isoform X1
chromodomain-helicase-DNA-binding protein 2 isoform X2
chromodomain-helicase-DNA-binding protein 2 isoform X3
chromodomain helicase DNA binding protein 2, transcript variant X4
chromodomain-helicase-DNA-binding protein 2 isoform X4
repulsive guidance molecule BMP co-receptor a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
repulsive guidance molecule BMP co-receptor a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
repulsive guidance molecule A isoform X1
repulsive guidance molecule A isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
peroxisomal biogenesis factor 11 alpha, transcript variant X2
peroxisomal biogenesis factor 11 alpha, transcript variant X3
peroxisomal biogenesis factor 11 alpha, transcript variant X1
peroxisomal biogenesis factor 11 alpha, transcript variant X6
peroxisomal biogenesis factor 11 alpha, transcript variant X4
peroxisomal biogenesis factor 11 alpha, transcript variant X5
peroxisomal membrane protein 11A isoform X2
peroxisomal membrane protein 11A isoform X1
peroxisomal biogenesis factor 11 alpha, transcript variant X7
peroxisomal membrane protein 11A isoform X3
peroxisomal biogenesis factor 11 alpha, transcript variant X8
peroxisomal membrane protein 11A isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
gonadotropin releasing hormone receptor 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 67 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
hyaluronan and proteoglycan link protein 3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
hyaluronan and proteoglycan link protein 3-like, transcript variant X2
hyaluronan and proteoglycan link protein 3-like
milk fat globule EGF and factor V/VIII domain containing b, transcript variant X2
milk fat globule EGF and factor V/VIII domain containing b, transcript variant X4
milk fat globule EGF and factor V/VIII domain containing b, transcript variant X1
milk fat globule EGF and factor V/VIII domain containing b, transcript variant X3
milk fat globule EGF and factor V/VIII domain containing b isoform X4
milk fat globule EGF and factor V/VIII domain containing b isoform X3
milk fat globule EGF and factor V/VIII domain containing b isoform X2
milk fat globule EGF and factor V/VIII domain containing b isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 14% coverage of the annotated genomic feature by RNAseq alignments
TopBP1-interacting, checkpoint, and replication regulator
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 108 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
transfer RNA arginine (anticodon UCG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
polymerase (DNA directed), gamma, transcript variant X6
polymerase (DNA directed), gamma, transcript variant X1
polymerase (DNA directed), gamma, transcript variant X2
polymerase (DNA directed), gamma, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
polymerase (DNA directed), gamma, transcript variant X3
polymerase (DNA directed), gamma, transcript variant X5
DNA polymerase subunit gamma-1 isoform X1
DNA polymerase subunit gamma-1 isoform X2
FA complementation group I, transcript variant X2
FA complementation group I, transcript variant X6
FA complementation group I, transcript variant X5
FA complementation group I, transcript variant X1
FA complementation group I, transcript variant X3
FA complementation group I, transcript variant X4
Fanconi anemia group I protein isoform X3
Fanconi anemia group I protein isoform X2
Fanconi anemia group I protein isoform X1
FA complementation group I, transcript variant X8
Fanconi anemia group I protein isoform X5
FA complementation group I, transcript variant X7
Fanconi anemia group I protein isoform X4
transfer RNA opal suppressor (anticodon UCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA arginine (anticodon ACG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
UDP-glucuronosyltransferase 2A2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 120 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
UDP-glucuronosyltransferase 2A2-like, transcript variant X7
UDP-glucuronosyltransferase 2A2-like, transcript variant X6
UDP-glucuronosyltransferase 2A2-like, transcript variant X2
UDP-glucuronosyltransferase 2A2-like, transcript variant X8
UDP-glucuronosyltransferase 2A2-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 120 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
UDP-glucuronosyltransferase 2A2-like, transcript variant X1
UDP-glucuronosyltransferase 2A2-like isoform X1
UDP-glucuronosyltransferase 2A2-like isoform X2
UDP-glucuronosyltransferase 2A2-like, transcript variant X9
UDP-glucuronosyltransferase 2A2-like, transcript variant X3
UDP-glucuronosyltransferase 2A2-like isoform X3
UDP-glucuronosyltransferase 2A2-like isoform X4
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 110 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 95 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
UDP-glucuronosyltransferase 2C1-like isoform X1
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: UDP-glucuronosyltransferase 2C1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 12% coverage of the annotated genomic feature by RNAseq alignments
kinesin family member 7, transcript variant X2
kinesin family member 7, transcript variant X3
kinesin family member 7, transcript variant X1
DET1 partner of COP1 E3 ubiquitin ligase, transcript variant X1
DET1 partner of COP1 E3 ubiquitin ligase, transcript variant X2
DET1 partner of COP1 E3 ubiquitin ligase, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
DET1 partner of COP1 E3 ubiquitin ligase, transcript variant X3
28S ribosomal protein S11, mitochondrial
mitochondrial ribosomal protein L46, transcript variant X1
mitochondrial ribosomal protein L46, transcript variant X2
39S ribosomal protein L46, mitochondrial isoform X1
39S ribosomal protein L46, mitochondrial isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cytosolic carboxypeptidase 4, transcript variant X1
cytosolic carboxypeptidase 4, transcript variant X2
gonadotropin-releasing hormone II receptor-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
poly (ADP-ribose) polymerase family, member 16
protein mono-ADP-ribosyltransferase PARP16
immunoglobulin superfamily, DCC subclass, member 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 11% coverage of the annotated genomic feature by RNAseq alignments
immunoglobulin superfamily DCC subclass member 3
immunoglobulin superfamily, DCC subclass, member 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
immunoglobulin superfamily DCC subclass member 4
dipeptidyl peptidase 8-like, transcript variant X2
dipeptidyl peptidase 8-like, transcript variant X1
dipeptidyl peptidase 8-like, transcript variant X3
solute carrier family 51 subunit beta, transcript variant X5
solute carrier family 51 subunit beta, transcript variant X1
solute carrier family 51 subunit beta, transcript variant X3
solute carrier family 51 subunit beta, transcript variant X2
solute carrier family 51 subunit beta, transcript variant X4
solute carrier family 51 subunit beta, transcript variant X6
solute carrier family 51 subunit beta isoform X1
solute carrier family 51 subunit beta isoform X2
kelch repeat and BTB (POZ) domain containing 13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 32% coverage of the annotated genomic feature by RNAseq alignments
kelch repeat and BTB domain-containing protein 13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
caseinolytic mitochondrial matrix peptidase chaperone subunit Xa, transcript variant X2
caseinolytic mitochondrial matrix peptidase chaperone subunit Xa, transcript variant X1
caseinolytic mitochondrial matrix peptidase chaperone subunit Xa isoform X2
caseinolytic mitochondrial matrix peptidase chaperone subunit Xa isoform X1
myelin expression factor 2, transcript variant X1
myelin expression factor 2, transcript variant X2
myelin expression factor 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 22% coverage of the annotated genomic feature by RNAseq alignments
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D, like, transcript variant X6
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D, like, transcript variant X3
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D, like, transcript variant X7
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D, like, transcript variant X4
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D, like, transcript variant X8
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D, like, transcript variant X10
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D, like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D, like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D, like, transcript variant X5
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D, like, transcript variant X9
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D, like isoform X2
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D, like isoform X4
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D, like isoform X1
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D, like isoform X3
uncharacterized LOC121270026, transcript variant X3
uncharacterized LOC121270026, transcript variant X2
uncharacterized LOC121270026, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 9% coverage of the annotated genomic feature by RNAseq alignments
NEDD4 E3 ubiquitin protein ligase a, transcript variant X1
NEDD4 E3 ubiquitin protein ligase a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
E3 ubiquitin-protein ligase NEDD4a isoform X1
E3 ubiquitin-protein ligase NEDD4a isoform X2
testis expressed 9, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
testis expressed 9, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
testis expressed 9, transcript variant X3
meiosis-specific nuclear structural protein 1
zinc finger protein 280D-like, transcript variant X1
zinc finger protein 280D-like, transcript variant X2
zinc finger protein 280D-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
zinc finger protein 280D-like, transcript variant X3
zinc finger protein 280D-like isoform X2
zinc finger protein 280D-like isoform X1
zinc finger protein 280D-like isoform X3
zinc finger protein 280D-like isoform X4
zinc finger protein 280D-like, transcript variant X6
zinc finger protein 280D-like, transcript variant X5
zinc finger protein 280D-like isoform X6
zinc finger protein 280D-like isoform X5
transcription factor 12, transcript variant X1
transcription factor 12, transcript variant X6
transcription factor 12, transcript variant X10
transcription factor 12, transcript variant X14
transcription factor 12, transcript variant X3
transcription factor 12, transcript variant X9
transcription factor 12, transcript variant X11
transcription factor 12, transcript variant X7
transcription factor 12, transcript variant X2
transcription factor 12, transcript variant X4
transcription factor 12, transcript variant X5
transcription factor 12, transcript variant X15
transcription factor 12, transcript variant X8
transcription factor 12, transcript variant X12
transcription factor 12, transcript variant X16
transcription factor 12, transcript variant X13
transcription factor 12, transcript variant X19
transcription factor 12, transcript variant X17
transcription factor 12, transcript variant X18
myocardial zonula adherens protein-like, transcript variant X1
myocardial zonula adherens protein-like, transcript variant X2
myocardial zonula adherens protein-like, transcript variant X3
myocardial zonula adherens protein-like isoform X1
myocardial zonula adherens protein-like isoform X2
myocardial zonula adherens protein-like isoform X3
aldehyde dehydrogenase 1 family, member A2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 74 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
aldehyde dehydrogenase 1 family, member A2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 96 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 113 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ADAM metallopeptidase domain 10a, transcript variant X1
ADAM metallopeptidase domain 10a, transcript variant X2
disintegrin and metalloproteinase domain-containing protein 10 isoform X1
disintegrin and metalloproteinase domain-containing protein 10 isoform X2
MINDY lysine 48 deubiquitinase 2, transcript variant X4
MINDY lysine 48 deubiquitinase 2, transcript variant X3
ubiquitin carboxyl-terminal hydrolase MINDY-2 isoform X3
MINDY lysine 48 deubiquitinase 2, transcript variant X1
MINDY lysine 48 deubiquitinase 2, transcript variant X2
ubiquitin carboxyl-terminal hydrolase MINDY-2 isoform X1
ubiquitin carboxyl-terminal hydrolase MINDY-2 isoform X2
SAFB-like, transcription modulator, transcript variant X5
SAFB-like, transcription modulator, transcript variant X3
SAFB-like, transcription modulator, transcript variant X2
SAFB-like, transcription modulator, transcript variant X1
SAFB-like, transcription modulator, transcript variant X4
SAFB-like transcription modulator isoform X5
SAFB-like transcription modulator isoform X4
SAFB-like transcription modulator isoform X3
SAFB-like transcription modulator isoform X2
SAFB-like transcription modulator isoform X1
ring finger protein 111, transcript variant X1
ring finger protein 111, transcript variant X3
ring finger protein 111, transcript variant X2
E3 ubiquitin-protein ligase Arkadia isoform X1
E3 ubiquitin-protein ligase Arkadia isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 59 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
centrosomal protein 152, transcript variant X3
centrosomal protein 152, transcript variant X2
centrosomal protein 152, transcript variant X4
centrosomal protein 152, transcript variant X1
centrosomal protein of 152 kDa isoform X3
centrosomal protein of 152 kDa isoform X2
centrosomal protein of 152 kDa isoform X4
centrosomal protein of 152 kDa isoform X1
centrosomal protein 152, transcript variant X5
centrosomal protein of 152 kDa isoform X5
transfer RNA valine (anticodon UAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
SHC-transforming protein 1-like, transcript variant X5
SHC-transforming protein 1-like, transcript variant X4
SHC-transforming protein 1-like, transcript variant X1
SHC-transforming protein 1-like isoform X1
SHC-transforming protein 1-like isoform X4
SHC-transforming protein 1-like isoform X5
SHC-transforming protein 1-like, transcript variant X2
SHC-transforming protein 4-like isoform X2
SHC-transforming protein 1-like, transcript variant X3
SHC-transforming protein 4-like isoform X3
regulator of G-protein signaling 7-binding protein-like
SECIS binding protein 2-like, transcript variant X2
SECIS binding protein 2-like, transcript variant X1
SECIS binding protein 2-like, transcript variant X3
SECIS binding protein 2-like, transcript variant X5
SECIS binding protein 2-like, transcript variant X4
SECIS binding protein 2-like, transcript variant X6
selenocysteine insertion sequence-binding protein 2-like isoform X2
selenocysteine insertion sequence-binding protein 2-like isoform X1
selenocysteine insertion sequence-binding protein 2-like isoform X3
COP9 signalosome subunit 2, transcript variant X2
COP9 signalosome subunit 2, transcript variant X1
COP9 signalosome complex subunit 2 isoform X2
COP9 signalosome complex subunit 2 isoform X1
COP9 signalosome subunit 2, transcript variant X3
COP9 signalosome complex subunit 2 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
fibroblast growth factor 7, transcript variant X2
fibroblast growth factor 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 25% coverage of the annotated genomic feature by RNAseq alignments
DTW domain containing 1, transcript variant X3
DTW domain containing 1, transcript variant X2
DTW domain containing 1, transcript variant X1
DTW domain containing 1, transcript variant X5
DTW domain containing 1, transcript variant X4
DTW domain containing 1, transcript variant X6
tRNA-uridine aminocarboxypropyltransferase 1
NAD(P) transhydrogenase, mitochondrial-like, transcript variant X1
NAD(P) transhydrogenase, mitochondrial-like, transcript variant X2
NAD(P) transhydrogenase, mitochondrial-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
NAD(P) transhydrogenase, mitochondrial-like
ATPase phospholipid transporting 8B4, transcript variant X2
ATPase phospholipid transporting 8B4, transcript variant X6
ATPase phospholipid transporting 8B4, transcript variant X4
ATPase phospholipid transporting 8B4, transcript variant X8
ATPase phospholipid transporting 8B4, transcript variant X3
ATPase phospholipid transporting 8B4, transcript variant X5
ATPase phospholipid transporting 8B4, transcript variant X7
ATPase phospholipid transporting 8B4, transcript variant X9
ATPase phospholipid transporting 8B4, transcript variant X1
ATPase phospholipid transporting 8B4, transcript variant X10
ATPase phospholipid transporting 8B4, transcript variant X11
phospholipid-transporting ATPase ID isoform X2
phospholipid-transporting ATPase ID isoform X1
phospholipid-transporting ATPase ID isoform X3
phospholipid-transporting ATPase ID isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 8% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC121269963, transcript variant X1
uncharacterized LOC121269963, transcript variant X2
family with sequence similarity 214 member A, transcript variant X4
family with sequence similarity 214 member A, transcript variant X7
family with sequence similarity 214 member A, transcript variant X3
family with sequence similarity 214 member A, transcript variant X1
family with sequence similarity 214 member A, transcript variant X5
family with sequence similarity 214 member A, transcript variant X6
family with sequence similarity 214 member A, transcript variant X2
family with sequence similarity 214 member A, transcript variant X8
family with sequence similarity 214 member A, transcript variant X11
family with sequence similarity 214 member A, transcript variant X10
family with sequence similarity 214 member A, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
guanine nucleotide-binding protein subunit beta-5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
mitogen-activated protein kinase 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 73 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
mitogen-activated protein kinase 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 291 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
tumor necrosis factor, alpha-induced protein 8-like 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
tumor necrosis factor alpha-induced protein 8-like protein 3
adaptor related protein complex 4 subunit epsilon 1, transcript variant X1
adaptor related protein complex 4 subunit epsilon 1, transcript variant X2
adaptor related protein complex 4 subunit epsilon 1, transcript variant X3
AP-4 complex subunit epsilon-1 isoform X1
AP-4 complex subunit epsilon-1 isoform X2
AP-4 complex subunit epsilon-1 isoform X3
secretogranin III, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
secretogranin III, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
secretogranin III, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
LysM, putative peptidoglycan-binding, domain containing 2, transcript variant X3
LysM, putative peptidoglycan-binding, domain containing 2, transcript variant X2
LysM, putative peptidoglycan-binding, domain containing 2, transcript variant X1
lysM and putative peptidoglycan-binding domain-containing protein 2
LEO1 homolog, Paf1/RNA polymerase II complex component
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns